Potential Therapeutic Value of Urotensin II Receptor Antagonist in Chronic Kidney Disease and Associated ComorbiditiesMarie‐Laure Ozoux, Philip Janiak, Michel Pelat et al.|Journal of Pharmacology and Experimental Therapeutics|2020Cited by 16